Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
MA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.3.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.3.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.81EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.81ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.81ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.81EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.81EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used